Helix Pharma SRL
Helix Pharma reported total assets of 875 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Helix Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Helix Pharma's annual accounts
| 2025 | |
|---|---|
| Net result | −2,851 € |
| Equity | −351 € |
| Cash | 532 € |
| EBITDA | −2,851 € |
| Total assets | 875 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
Helix Pharma's financial analysis
Management and control of Helix Pharma
Helix Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1031.108.218
- VAT number
- BE1031108218
- Peppol
- Registered · 0208:1031108218 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Dec 2025
- Registered office
- 2970 Schilde
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Intermediation service activities for specialised retail sale (NACE 47920)
Helix Pharma (SRL) has been based in Schilde since 2025, active in: intermediation service activities for specialised retail sale. For 2025, it reports a net loss of 2,851 € and equity of −351 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Helix Pharma
Companies in the same business, of comparable size and area, outside its group.
- Sarbat Retail sale of information and communication equipment Antwerp · balance sheet 139,854 €
- Real Balance For Life Intermediation service activities for specialised retail sale Wommelgem · balance sheet 23,335 €
- Fleuropean Intermediation service activities for non-specialised retail sale Dalhem · balance sheet 26,021 €
- Art Promotion Intermediation service activities for specialised retail sale Leuven · balance sheet 17,116 €
- Dagoty Intermediation service activities for specialised retail sale Brussels · balance sheet 177,852 €
- Pauline Darquennes Intermediation service activities for specialised retail sale Bornem · balance sheet 49,318 €
- Cruxa Intermediation service activities for specialised retail sale Ghent · balance sheet 53,013 €
- AkinLab Intermediation service activities for specialised retail sale Vilvoorde · balance sheet 99,750 €
Frequently asked questions about Helix Pharma
What is the revenue of Helix Pharma?
Helix Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Helix Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE1031108218 for Helix Pharma, if the company is VAT-registered. Its company number (CBE) is 1031.108.218.
Where is the registered office of Helix Pharma?
According to the CBE register, the registered office of Helix Pharma is in 2970 Schilde.
Who manages Helix Pharma?
The register lists 1 active mandates at Helix Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Helix Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →